Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering

Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered int...

Full description

Saved in:
Bibliographic Details
Main Author: Valentina Di Felice (auth)
Other Authors: Giancarlo Forte (auth), Dario Coletti (auth)
Format: Electronic Book Chapter
Language:English
Published: Frontiers Media SA 2016
Series:Frontiers Research Topics
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_42266
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2016 xx |||||o ||| 0|eng d
020 |a 978-2-88919-841-2 
020 |a 9782889198412 
040 |a oapen  |c oapen 
024 7 |a 10.3389/978-2-88919-841-2  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MFG  |2 bicssc 
100 1 |a Valentina Di Felice  |4 auth 
700 1 |a Giancarlo Forte  |4 auth 
700 1 |a Dario Coletti  |4 auth 
245 1 0 |a Biomaterials and Bioactive Molecules to Drive Differentiation in Striated Muscle Tissue Engineering 
260 |b Frontiers Media SA  |c 2016 
300 |a 1 electronic resource (90 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers Research Topics 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Tissue engineering is an innovative, multidisciplinary approach which combines (bio)materials, cells and growth factors with the aim to obtain neo-organogenesis to repair or replenish damaged tissues and organs. The generation of engineered tissues and organs (e. g. skin and bladder) has entered into the clinical practice in response to the chronic lack of organ donors. In particular, for the skeletal and cardiac muscles the translational potential of tissue engineering approaches has clearly been shown, even though the construction of this tissue lags behind others given the hierarchical, highly organized architecture of striated muscles. Cardiovascular disease is the leading cause of death in the developed world, where the yearly incidence of Acute MI (AMI) is approx 2 million cases in Europe. Recovery from AMI and reperfusion is still less than ideal. Stem cell therapy may represent a valid treatment. However, delivery of stem cells alone to infarcted myocardium provides no structural support while the myocardium heals, and the injected stem cells do not properly integrate into the myocardium because they are not subjected to the mechanical forces that are known to drive myocardial cellular physiology. On the other hand, there are many clinical cases where the loss of skeletal muscle due to a traumatic injury, an aggressive tumour or prolonged denervation may be cured by the regeneration of this tissue. In vivo, stem or progenitor cells are sheltered in a specialized microenvironment (niche), which regulates their survival, proliferation and differentiation. The goal of this research topic is to highlight the available knowledge on biomaterials and bioactive molecules or a combination of them, which can be used successfully to differentiate stem or progenitor cells into beating cardiomyocytes or organized skeletal muscle in vivo. Innovations compared to the on-going trials may be: 1) the successful delivery of stem cells using sutural scaffolds instead of intracoronary or intramuscular injections; 2) protocols to use a limited number of autologous or allogeneic stem cells; 3) methods to drive their differentiation by modifying the chemical-physical properties of scaffolds or biomaterials, incorporating small molecules (i.e. miRNA) or growth factors; 4) methods to tailor the scaffolds to the elastic properties of the muscle; 5) studies which suggest how to realize scaffolds that optimize tissue functional integration, through the combination of the most up-to-date manufacturing technologies and use of bio-polymers with customized degradation properties. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Physiology  |2 bicssc 
653 |a Angiogenesis 
653 |a Scaffold 
653 |a cardiac stem cells 
653 |a skeletal muscle 
653 |a Biomaterials 
653 |a Tissue Engineering 
653 |a satellite cells 
856 4 0 |a www.oapen.org  |u http://journal.frontiersin.org/researchtopic/1967/biomaterials-and-bioactive-molecules-to-drive-differentiation-in-striated-muscle-tissue-engineering  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/42266  |7 0  |z DOAB: description of the publication